IDBS Acquires InforSense to Provide End-to-End Solutions for R&D Data Management
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
IDBS has announced that it has concluded an unconditional agreement to acquire InforSense Ltd (InforSense), a company providing scientific and business intelligence (BI) technologies, in an all-cash transaction. The acquisition will complete in July.
R&D organizations in the public and private sectors rely upon their ability to capture, integrate and interpret their data. This is hampered by the explosion in volume and diversity of data available to scientists, the global scale of modern R&D activities and the requirement for data to be accessed and searched in context.
InforSense’s data integration technologies and web-based interactive analytics complement IDBS’ suite of secure, context-rich data management solutions. This transaction creates a supplier who can deliver the entire capture, integration and decision-making infrastructure for R&D organizations worldwide.
With the addition of the InforSense product portfolio, IDBS will expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine.
R&D organizations in the public and private sectors rely upon their ability to capture, integrate and interpret their data. This is hampered by the explosion in volume and diversity of data available to scientists, the global scale of modern R&D activities and the requirement for data to be accessed and searched in context.
InforSense’s data integration technologies and web-based interactive analytics complement IDBS’ suite of secure, context-rich data management solutions. This transaction creates a supplier who can deliver the entire capture, integration and decision-making infrastructure for R&D organizations worldwide.
With the addition of the InforSense product portfolio, IDBS will expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine.
